Commentary : Combating COVID-19-associated mucormycosis with limited resources.
作者信息
Kim Usha, Kulkarni Pooja, Saini Pragya
机构信息
Department of Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthesis, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Madurai, Tamil Nadu, India.
出版信息
Indian J Ophthalmol. 2022 Jun;70(6):2169. doi: 10.4103/ijo.IJO_1250_22.
Abstract
摘要
相似文献
1
Commentary : Combating COVID-19-associated mucormycosis with limited resources.评论：利用有限资源对抗新型冠状病毒肺炎相关毛霉病
Indian J Ophthalmol. 2022 Jun;70(6):2169. doi: 10.4103/ijo.IJO_1250_22.
2
Mucormycosis: The hidden and forgotten disease.毛霉菌病：被忽视的隐匿性疾病。
J Appl Microbiol. 2022 Jun;132(6):4042-4057. doi: 10.1111/jam.15487. Epub 2022 Feb 23.
3
Mucormycosis in COVID-19: The Indian scenario.新型冠状病毒肺炎相关毛霉菌病：印度的情况
J Mycol Med. 2022 Aug;32(3):101275. doi: 10.1016/j.mycmed.2022.101275. Epub 2022 Mar 23.
4
The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?印度新冠后毛霉菌病的出现：我们能预防它吗？
Indian J Ophthalmol. 2021 Jul;69(7):1645-1647. doi: 10.4103/ijo.IJO_1392_21.
5
Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients.新冠疫情期间毛霉菌病的风险：免疫功能低下和免疫功能正常患者均面临的临床挑战。
Mol Biol Rep. 2022 Jun;49(6):4977-4988. doi: 10.1007/s11033-022-07160-3. Epub 2022 Feb 2.
6
Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B.对一名可能患有脑毛霉病且接受静脉注射脂质体两性霉素B治疗的患者脑脊液中毛霉目DNA载量的评估。
Int J Infect Dis. 2014 Dec;29:200-2. doi: 10.1016/j.ijid.2014.10.019. Epub 2014 Nov 6.
7
Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.年轻男性发生鼻眶脑毛霉菌病导致双眼失明：病例报告。
Indian J Ophthalmol. 2022 May;70(5):1822-1824. doi: 10.4103/ijo.IJO_3141_21.
8
Commentary: COVID-19-associated mucormycosis: The ongoing battle.评论：新型冠状病毒肺炎相关毛霉菌病：持续的斗争
Indian J Ophthalmol. 2021 Dec;69(12):3683-3684. doi: 10.4103/ijo.IJO_2789_21.
9
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.印度 COVID-19 相关毛霉病爆发期间医院环境中存在毛霉科的评估 - 一项多中心研究。
J Hosp Infect. 2022 Apr;122:173-179. doi: 10.1016/j.jhin.2022.01.016. Epub 2022 Feb 3.
10
A Case of Esophageal Mucormycosis.一例食管毛霉菌病
Am J Gastroenterol. 2022 Feb 1;117(2):355. doi: 10.14309/ajg.0000000000001592.
引用本文的文献
1
Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.COVID-19 大流行期间的鼻-眶-脑毛霉病及其再现：综述。
Indian J Ophthalmol. 2023 Jan;71(1):39-56. doi: 10.4103/ijo.IJO_1219_22.
本文引用的文献
1
Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.印度北部一家三级护理中心 COVID-19 相关的鼻眶脑毛霉菌病患者分析。
Indian J Ophthalmol. 2022 Jun;70(6):2163-2168. doi: 10.4103/ijo.IJO_340_22.
2
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India.印度一家多专科三级保健中心 COVID-19 后毛霉菌病的累积死亡率及相关预后因素。
JAMA Ophthalmol. 2022 Jan 1;140(1):66-72. doi: 10.1001/jamaophthalmol.2021.5201.
3
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
4
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究（COSMIC），报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
5
Outcomes of a Modified Treatment Ladder Algorithm Using Retrobulbar Amphotericin B for Invasive Fungal Rhino-Orbital Sinusitis.使用球后注射两性霉素B治疗侵袭性真菌性鼻-眶-鼻窦炎的改良治疗阶梯算法的结果
Am J Ophthalmol. 2022 May;237:299-309. doi: 10.1016/j.ajo.2021.05.025. Epub 2021 Jun 9.
Zotero 插件